Enclear Therapies logo
Healthcare & Life Sciences

Enclear Therapies

EnClear Therapies is a series a startup based in United States. 1 investor tracked.

Activeseries-a
series-a
Stage
1
Investors

About Enclear Therapies

Enclear Therapies is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

EnClear Therapies develops a proprietary EnTrega CSF Platform to improve and extend the lives of patients with central nervous system (CNS) diseases through precision dosing, initially focusing on neuro-oncology and planning expansion into neurodegenerative, lysosomal storage, and autoimmune diseases.

Explore Enclear Therapies's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States